Metraipolis › archive › dc_3ffe551e2adb

CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42636059
DOI
10.1158/2767-9764.crc-25-0799
License (as archived)
solo-consultazione
Archived
2026-10-16T12:59:23.898Z
SHA-256 of the archived text
037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00
Stable URL of this page
https://metraipolis.com/documento/dc_3ffe551e2adb

How to cite

CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059 — Europe PMC (en), https://europepmc.org/article/MED/42636059 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ffe551e2adb (Metraipolis archive dc_3ffe551e2adb, sha256 037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00)
BibTeX
@misc{dc3ffe551e2adb,
  title = {CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors — Europe PMC PMID:42636059},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42636059},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ffe551e2adb; sha256 037cd44ea3a2b7bdc0e43501f150833e08ee00d2ba8f5e576e797c1d9ec02c00},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42636059. Agents can read the archived copy with the MCP tool read_document.